Literature DB >> 6322634

Enalapril, a rash, and captopril.

S H Kubo, R J Cody.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6322634     DOI: 10.7326/0003-4819-100-4-616_1

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

Review 1.  Perindopril safety and tolerance in at-risk patients.

Authors:  S Brichard; A E Lambert
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 2.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr

Review 3.  Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  P A Todd; R C Heel
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

Review 4.  Enalapril. An update of its pharmacological properties and therapeutic use in congestive heart failure.

Authors:  P A Todd; K L Goa
Journal:  Drugs       Date:  1989-02       Impact factor: 9.546

5.  Tolerability of long term therapy with enalapril maleate in patients resistant to other therapies and intolerant to captopril.

Authors:  E J Rucinska; R Small; W S Mulcahy; D L Snyder; P V Rodel; J E Rush; R D Smith; J F Walker; J D Irvin
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr

Review 6.  Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update.

Authors:  R C Parish; L J Miller
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

Review 7.  Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension.

Authors:  P A Todd; K L Goa
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.